sb 203580 has been researched along with deoxyribose in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (deoxyribose) | Trials (deoxyribose) | Recent Studies (post-2010) (deoxyribose) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 990 | 0 | 155 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, S; Che, XF; Furukawa, T; Haraguchi, M; Ikeda, R; Nakajima, Y; Okumura, H; Shibayama, Y; Sumizawa, T; Takeda, Y; Ushiyama, M; Yamada, K; Yamaguchi, T; Yamamoto, M | 1 |
1 other study(ies) available for sb 203580 and deoxyribose
Article | Year |
---|---|
2-Deoxy-D-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPK.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Hypoxia; Cell Line, Tumor; Cell Polarity; Cell Shape; Deoxyribose; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Transport; Pyridines | 2006 |